Metallothionein - a promising tool for cancer diagnostics

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F09%3A00113904" target="_blank" >RIV/00216224:14310/09:00113904 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/09:5473 RIV/00216208:11130/09:5473
Result on the web
<a href="http://bmj.fmed.uniba.sk/2009/11002-06.pdf" target="_blank" >http://bmj.fmed.uniba.sk/2009/11002-06.pdf</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Metallothionein - a promising tool for cancer diagnostics
Original language description
The latest research outcomes indicate that metallothionein (MT) levels in peripheral blood and serum from cancer patients can provide many interesting information about type or clinical stage of the disease, or response to therapy. MT plays a key role in transport of essential heavy metals, detoxification of toxic metals and protection of cells against oxidation stress. Serum MT levels of cancer patients are three times higher than control patients (0.5 mu M). The elevated MT levels in cancer cells are probably related to their increased proliferation and protection against apoptosis. Automated electrochemical detection of MT allows its serial analysis in a very small volume with excellent sensitivity, reliability and reproducibility and therefore it can be considered as a new tool for cancer diagnosis (Fig. 4, Ref. 55). Full Text (Free, PDF) www.bmj.sk.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30218 - General and internal medicine

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)